PPARβ/δ exerts a variety of metabolic effects and physiological actions [25,26,27,28,29], and PPARβ/δ activation may inhibit and improve obesity-related metabolic disorders. This evidence concerns the gene PPARD and obesity due to melanocortin 4 receptor deficiency.